Health ❯Medicine

Clinical Trials

Drug Development Phase 3 Trials Drug Testing Research Studies Human Trials Drug Trials Cancer Research Drug Efficacy Drug Approval Research

GSDMD Inhibitor YM81 Lowers Liver Injury Markers in Acetaminophen-Overdose Mice

Findings presented at the ACS meeting remain preclinical.

Blocking DKK1 Reprograms Neutrophils and Revives Immunotherapy in Bone Metastases

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models

UC San Diego Launches Clinical Trial of Sequenced Radiotherapy and Immunotherapy for Head and Neck Cancer

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

Illusia Probe Maps Signaling That Drives Breast Cancer Cell Invasion

Therapeutic Plasma Exchange with IVIG Reverses Biological Age by 2.61 Years

Blocking EPO Signaling Eliminates Immune-Resistant Liver Tumors in Mice

Statins Linked to 61% Reduced Cancer Mortality in CLL and SLL Patients

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

Aspirin Shows Potential in Preventing Cancer Spread Through Immune Boost

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Glaucoma Drug Shows Promise in Combating Alzheimer's and Dementia

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Gene Therapy Shows Promise in Restoring Vision for Patients with Rare Genetic Disorder

New Pill Significantly Boosts IVF Success Rates

FDA Approves Donanemab: A Breakthrough in Early Alzheimer’s Treatment

Ketamine Shows Promise for Treatment-Resistant Depression in Clinical Trials

UK Boy Receives Groundbreaking Brain Implant for Severe Epilepsy